Anti-tumour necrosis factor-associated cutaneous leishmaniasis: a single-institution experience

Br J Dermatol. 2019 Aug;181(2):403-405. doi: 10.1111/bjd.17644. Epub 2019 May 6.

Authors

A Martínez-Doménech¹, M García-Legaz-Martínez¹, J Magdaleno-Tapial¹, M Torrecillas², P Hernández-Bel¹, M D Ocete Mochón², A Pérez-Ferriols¹, V Alegre de Miquel¹

Affiliations

¹ Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain.
² Department of Microbiology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain.

PMID: 30659588
DOI: 10.1111/bjd.17644

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
DNA, Protozoan / isolation & purification
Female
Humans
Immunosuppressive Agents / adverse effects*
Leishmania donovani / genetics
Leishmania donovani / isolation & purification
Leishmania infantum / genetics
Leishmania infantum / isolation & purification
Leishmaniasis, Cutaneous / diagnosis*
Leishmaniasis, Cutaneous / immunology
Leishmaniasis, Cutaneous / parasitology
Leishmaniasis, Cutaneous / pathology
Male
Middle Aged
Skin / parasitology
Skin / pathology
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / immunology
Young Adult

Substances

DNA, Protozoan
Immunosuppressive Agents
TNF protein, human
Tumor Necrosis Factor-alpha